Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolberg, W. H.
Right arrow Articles by Mangasarian, O. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolberg, W. H.
Right arrow Articles by Mangasarian, O. L.
Clinical Cancer Research Vol. 5, 3542-3548, November 1999
© 1999 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Importance of Nuclear Morphology in Breast Cancer Prognosis

William H. Wolberg1, W. Nick Street and Olvi L. Mangasarian

Department of Surgery, University of Wisconsin, Madison, Wisconsin 53792 [W. H. W.]; Management Sciences Department, University of Iowa, Iowa City, Iowa 52242 [W. N. S.]; and Computer Sciences Department, University of Wisconsin, Madison, Wisconsin 53706 [O. L. M.]

The purpose of this study is to define prognostic relationships between computer-derived nuclear morphological features, lymph node status, and tumor size in breast cancer. Computer-derived nuclear size, shape, and texture features were determined in fine-needle aspirates obtained at the time of diagnosis from 253 consecutive patients with invasive breast cancer. Tumor size and lymph node status were determined at the time of surgery. Median follow-up time was 61.5 months for patients without distant recurrence. In univariate analysis, tumor size, nuclear features, and the number of metastatic nodes were of decreasing significance for distant disease-free survival. Nuclear features, tumor size, and the number of metastatic nodes were of decreasing significance for overall survival. In multivariate analysis, the morphological size feature, largest perimeter, was more predictive of disease-free and overall survival than were either tumor size or the number of axillary lymph node metastases. This morphological feature, when combined with tumor size, identified more patients at both the good and poor ends of the prognostic spectrum than did the combination of tumor size and axillary lymph node status. Our data indicate that computer analysis of nuclear features has the potential to replace axillary lymph node status for staging of breast cancer. If confirmed by others, axillary dissection for breast cancer staging, estimating prognosis, and selecting patients for adjunctive therapy could be eliminated.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Hoque, S. M. Lippman, I. V. Boiko, E. N. Atkinson, N. Sneige, A. Sahin, D. M. Weber, S. Risin, M. D. Lagios, R. Schwarting, et al.
Quantitative Nuclear Morphometry by Image Analysis for Prediction of Recurrence of Ductal Carcinoma in Situ of the Breast
Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 249 - 259.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.